Prestige Consumer Healthcare (PBH) Depreciation & Amortization - Total (2011 - 2025)

Prestige Consumer Healthcare (PBH) recorded quarterly Depreciation & Amortization - Total of $2.4 million in Q4 2025, down 1.97% quarter-over-quarter from $2.5 million in Q3 2025, and up 28.04% on a YoY basis from $1.9 million in Q4 2024.

Prestige Consumer Healthcare (PBH) Depreciation & Amortization - Total (2011 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Depreciation & Amortization - Total history runs 15 years deep, the most recent figure standing at $2.4 million for Q4 2025.

  • In Q4 2025, Depreciation & Amortization - Total rose 28.04% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $10.4 million (up 16.75% YoY), while the FY2025 annual figure was $9.7 million, up 18.29% from the prior year.
  • Depreciation & Amortization - Total was $2.4 million for Q4 2025 at Prestige Consumer Healthcare, down from $2.5 million in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $3.9 million in Q1 2021 to a low of $1.8 million in Q3 2021.
  • Historically, Depreciation & Amortization - Total has averaged $2.2 million across 5 years, with a median of $2.0 million in 2023.
  • The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization - Total surged 261.34% in 2021, then sank 54.43% in 2022.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $1.8 million in 2021, then climbed by 3.6% to $1.9 million in 2022, then grew by 7.38% to $2.0 million in 2023, then fell by 5.03% to $1.9 million in 2024, then climbed by 28.04% to $2.4 million in 2025.
  • The last three Depreciation & Amortization - Total figures came in at $2.4 million (Q4 2025), $2.5 million (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Prestige Consumer Healthcare 2.33 Bn 2.26 Bn 157.37 Mn 2.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.44 Mn
Sep 30, 2025 2.49 Mn
Jun 30, 2025 2.48 Mn
Mar 31, 2025 3.01 Mn
Dec 31, 2024 1.91 Mn
Sep 30, 2024 2.36 Mn
Jun 30, 2024 2.42 Mn
Mar 31, 2024 2.24 Mn
Dec 31, 2023 2.01 Mn
Sep 30, 2023 1.97 Mn
Jun 30, 2023 1.98 Mn
Mar 31, 2023 2.01 Mn
Dec 31, 2022 1.87 Mn
Sep 30, 2022 1.88 Mn
Jun 30, 2022 1.94 Mn
Mar 31, 2022 1.79 Mn
Dec 31, 2021 1.81 Mn
Sep 30, 2021 1.79 Mn
Jun 30, 2021 1.83 Mn
Mar 31, 2021 3.94 Mn